Search

Displaying results 8941 - 8950 of 10000 in total
  1. Drug

    NN-8828

    go.drugbank.com/drugs/DB18361
    Investigational

    NN-8828 is an anti-interleukin 21 monoclonal antibody.

  2. Drug

    SYNB1891

    go.drugbank.com/drugs/DB17541
    Investigational

    [A256733] SYNB1891 is under investigation in clinical trial NCT04167137 (Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects). … SYNB1891 is a live, modified strain of the probiotic _Escherichia coli_ Nissle engineered to produce cyclic di-AMP (CDA), a stimulator of the STING (STimulator of INterferon Genes) pathway.

  3. Drug

    Lifirafenib

    go.drugbank.com/drugs/DB14773
    Investigational

    Lifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor).

  4. Drug

    Prasinezumab

    go.drugbank.com/drugs/DB14788
    Investigational

    Prasinezumab is under investigation in clinical trial NCT03100149 (A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease).

  5. Drug

    Balovaptan

    go.drugbank.com/drugs/DB14823
    Investigational

    Balovaptan is under investigation in clinical trial NCT01793441 (A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)).

  6. Drug

    AZD-8848

    go.drugbank.com/drugs/DB14868
    Investigational

    AZD-8848 is under investigation in clinical trial NCT01818869 (To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects).

  7. Drug

    Tenofovir exalidex

    go.drugbank.com/drugs/DB14925
    Investigational

    Tenofovir exalidex is under investigation in clinical trial NCT01080820 (A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers).

  8. Drug

    LGH-447

    go.drugbank.com/drugs/DB14943
    Investigational

    LGH-447 is under investigation in clinical trial NCT02160951 (Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies).

  9. Drug

    Otlertuzumab

    go.drugbank.com/drugs/DB16275
    Investigational

    Otlertuzumab is under investigation in clinical trial NCT01188681 (Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia).

  10. Drug

    Pelcitoclax

    go.drugbank.com/drugs/DB16285
    Investigational

    Pelcitoclax is under investigation in clinical trial NCT04210037 (Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/refractory Small Cell Lung Cancer).